ABVC BioPharma, Inc. (ABVC): Price and Financial Metrics

ABVC BioPharma, Inc. (ABVC): $0.63

0.01 (-0.97%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add ABVC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#326 of 340

in industry

ABVC Price/Volume Stats

Current price $0.63 52-week high $1.73
Prev. close $0.64 52-week low $0.40
Day low $0.63 Volume 186,800
Day high $0.66 Avg. volume 647,369
50-day MA $0.57 Dividend yield N/A
200-day MA $0.65 Market Cap 8.21M

ABVC Stock Price Chart Interactive Chart >


ABVC BioPharma, Inc. (ABVC) Company Bio


American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company was incorporated in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.


ABVC Latest News Stream


Event/Time News Detail
Loading, please wait...

ABVC Latest Social Stream


Loading social stream, please wait...

View Full ABVC Social Stream

ABVC Price Returns

1-mo 44.16%
3-mo 21.20%
6-mo -8.72%
1-year -48.36%
3-year -97.24%
5-year N/A
YTD 6.78%
2024 -49.14%
2023 -81.44%
2022 -81.56%
2021 -33.53%
2020 16.70%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!